JAZZ EPS Estimates
Jazz Pharmaceuticals plc
$210.80
-$5.96(-2.75%)
55
Overall
60
Value
45
Tech
60
Quality
Market Cap
$14.18B
Volume
405.74K
52W Range
$128.80 - $266.38
Target Price
$295.64
JAZZ EPS estimates: the consensus estimate for Jazz Pharmaceuticals plc's current fiscal year is $21.59 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
JAZZ EPS Estimates
- EPS estimate, current quarter
- $5.66
- EPS estimate, next quarter
- $5.96
- EPS estimate, current year
- $21.59
- EPS estimate, next year
- $22.18
- EPS growth, 3-year
- -17.72%
| Fiscal year | EPS |
|---|---|
| 2025 | $-5.84 |
| 2024 | $9.06 |
| 2023 | $6.55 |
| 2022 | $-3.58 |
| 2021 | $-5.52 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | JAZZ | $210.80 | -2.7% | 405.74K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Jazz Pharmaceuticals plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW